Summit Therapeutics logo

Summit Therapeutics Share Price (NASDAQ: SMMT)

$25.14

-0.21

(-0.83%)

Live

Last updated on

Check the interactive Summit Therapeutics Stock chart to analyse performance

Summit Therapeutics stock performance

as on August 20, 2025 at 11:37 PM IST

  • Today's Low:$24.80
    Today's High:$25.44

    Day's Volatility :2.52%

  • 52 Weeks Low:$11.76
    52 Weeks High:$36.91

    52 Weeks Volatility :68.14%

Summit Therapeutics Stock Returns

PeriodSummit Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-0.16%
1.5%
0.0%
6 Months
17.45%
-7.1%
0.0%
1 Year
106.09%
-11.4%
0.0%
3 Years
1456.44%
2.9%
-9.6%

Summit Therapeutics Inc Key Stats

Check Summit Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$25.35
Open
$25.5
Today's High
$25.51
Today's Low
$24.8
Market Capitalization
$19.5B
Today's Volume
$2.4M
52 Week High
$36.91
52 Week Low
$11.76
Revenue TTM
$0.0
EBITDA
$-759.2M
Earnings Per Share (EPS)
$-1.01
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-328.3%

Stock Returns calculator for Summit Therapeutics Stock including INR - Dollar returns

The Summit Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Summit Therapeutics investment value today

Current value as on today

₹2,08,113

Returns

₹1,08,113

(+108.11%)

Returns from Summit Therapeutics Stock

₹1,04,224 (+104.22%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Summit Therapeutics Stock

-2.88%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Investment in Summit Therapeutics Shares from India has dropped by -2.88% over the past 30 days, indicating reduced transactional activity.

-29%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Summit Therapeutics Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Summit Therapeutics Inc

  • Name

    Holdings %

  • Baker Bros Advisors LP

    3.29%

  • FMR Inc

    1.26%

  • Vanguard Group Inc

    1.17%

  • BlackRock Inc

    1.13%

  • State Street Corp

    0.65%

  • T. Rowe Price Associates, Inc.

    0.53%

Analyst Recommendation on Summit Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Summit Therapeutics(by analysts ranked 0 to 5 stars)

Summit Therapeutics Share Price Target

What analysts predicted

Upside of 33.91%

Target:

$33.67

Current:

$25.14

Summit Therapeutics share price target is $33.67, a slight Upside of 33.91% compared to current price of $25.14 as per analysts' prediction.

Summit Therapeutics Stock Insights

  • Price Movement

    In the last 3 years, SMMT stock has moved up by 2206.4%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 235.0K → -235.0K (in $), with an average decrease of 100.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -56.25M → -565.70M (in $), with an average decrease of 270.3% per quarter

Summit Therapeutics Technicals Summary

Sell

Neutral

Buy

Summit Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Summit Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Summit Therapeutics Inc logo
-3.68%
17.45%
106.09%
1456.44%
637.5%
Regeneron Pharmaceuticals, Inc. logo
4.65%
-16.73%
-52.11%
-6.73%
-5.71%
Beone Medicines Ltd logo
7.16%
32.17%
61.08%
80.84%
30.07%
Vertex Pharmaceuticals Incorporated logo
-14.79%
-17.19%
-19.84%
32.96%
44.01%
Alnylam Pharmaceuticals, Inc. logo
43.03%
83.01%
63.29%
110.39%
235.62%

About Summit Therapeutics Inc

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.
Organization
Summit Therapeutics
Employees
159
CEO
Dr. Mahkam Zanganeh D.D.S., M.B.A.
Industry
Health Technology

Key Management of Summit Therapeutics Inc

NameTitle
Mr. Robert W. Duggan
Co-CEO & Executive Chairman
Dr. Mahkam Zanganeh D.D.S., M.B.A.
Co-CEO, President & Director
Mr. Manmeet Singh Soni CPA
COO, CFO & Director
Prof. Dame Kay Davies DBE, FRS CBE
Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
Mr. Dave Gancarz
Chief Business & Strategy Officer
Dr. Fong Clow
Chief Biometrics Officer
Ms. Shelley D. Spray
Chief Education & Brand Officer
Dr. Urte Gayko Ph.D.
Chief Regulatory, Quality & Pharmacovigilance Officer
Dr. Allen S. Yang M.D., Ph.D.
Chief Medical Officer
Dr. Laura Q. M. Chow M.D.
Senior Vice President of Clinical Development

Important FAQs about investing in SMMT Stock from India :

What is Summit Therapeutics share price today?

Summit Therapeutics share price today is $25.14 as on . Summit Therapeutics share today touched a day high of $25.44 and a low of $24.80.

What is the 52 week high and 52 week low for Summit Therapeutics share?

Summit Therapeutics share touched a 52 week high of $36.91 and a 52 week low of $11.76. Summit Therapeutics stock price today i.e. is trending at $25.14, lower by 31.89% versus the 52 week high.

How to invest in Summit Therapeutics Stock (SMMT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Summit Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Summit Therapeutics Shares that will get you 0.0597 shares as per Summit Therapeutics share price of $25.14 per share as on August 20, 2025 at 11:37 PM IST.

What is the minimum amount required to buy Summit Therapeutics Stock (SMMT) from India?

Indian investors can start investing in Summit Therapeutics (SMMT) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Summit Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Summit Therapeutics share’s latest price of $25.14 as on August 20, 2025 at 11:37 PM IST, you will get 0.3978 shares of Summit Therapeutics. Learn more about fractional shares .

What are the returns that Summit Therapeutics has given to Indian investors in the last 5 years?

Summit Therapeutics stock has given 637.5% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?